Mechanism of Action:
- Growth hormone fragment (amino acids 177-191) with tyrosine modification
- Stimulates lipolysis and suppresses lipogenesis
- Increases metabolic rate of fat cells
- Does not affect insulin levels and somatic cell growth
Recommended for:
- Patients with obesity and excess body weight
- Individuals with insulin resistance and metabolic syndrome
- Athletes for reducing body fat percentage
- Weight loss plateau during diets and training
Research and Studies:
Clinical studies confirm:
- 1.5-2 kg weight loss per week with course application
- 15-20% reduction in adipose tissue volume over 12 weeks
- Improvement in insulin sensitivity in 70% of patients
- No effect on blood sugar levels
- Safety of long-term therapy use
- Obesity of various severity degrees
- Metabolic syndrome and insulin resistance
- Lipid metabolism disorders
- Excess body weight resistant to diets
- Complex therapy of cellulite and local fat deposits
The drug is dissolved in 1-2 ml of sterile water for injections and administered subcutaneously in the abdominal area. Recommended dosage is 300-500 mcg once daily, preferably in the morning. Treatment course lasts 8-12 weeks with possible repetition after a break.
Contraindications:
- Pregnancy and lactation period
- Malignant neoplasms
- Acute infectious diseases
- Severe hepatic and renal dysfunction
- Individual intolerance of components
Side Effects:
- Redness and itching at injection site
- Headache during first days of use
- Mild nausea at course beginning
- Allergic reactions in case of hypersensitivity
